BioSante reacquires gel license
LINCOLNSHIRE - BioSante Pharmaceuticals Inc. announced Thursday that it has reacquired Elestrin (estradiol gel) from Nycomed US which in February acquired Bradley Pharmaceuticals Inc., BioSante's previous licensee of Elestrin. BioSante immediately will assume all manufacturing, distribution and marketing responsibilities for Elestrin. Elestrin is a fast-drying gel formulation of estradiol, the same estrogen produced naturally in women, and is U.S. Food and Drug Administration approved for the treatment of hot flashes in menopausal women.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.